Clinical Trial Update: Nattokinase Supplementation and Hemostatic Factors [Phase 4]

View source ↗

Summary

Phase 4 trial update on nattokinase supplementation evaluating its impact on hemostatic factors in individuals with hypercholesterolemia; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Nattokinase (Nattokinase)

Snippet

Sponsor: Yonsei University | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED